专家笔谈

先天性心脏病宫内介入治疗现状与展望

  • 陈笋
展开
  • 上海交通大学医学院附属新华医院儿心脏中心(上海 200092)

收稿日期: 2024-09-12

  网络出版日期: 2024-10-08

The current status and prospects of fetal cardiac intervention for congenital heart diseases

  • Sun CHEN
Expand
  • Department of Pediatric Cardiology, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China

Received date: 2024-09-12

  Online published: 2024-10-08

摘要

胎儿宫内心脏介入治疗(FCI)技术自1991年起发展至今,随着技术成功率的提高、并发症的减少及对患胎预后的改善,该技术已逐步获得医学界的认可与推广。国际胎儿心脏介入注册数据库的建立促进了该技术的国际间交流和技术发展,国际报道临床病例已逾400例。在国内,迄今已有广东、上海、青岛、重庆等多家医疗机构开展宫内心脏介入治疗,但病例数仍有限。文章从胎儿宫内心脏介入治疗的种类、操作过程、手术并发症、治疗指征以及治疗结局进行综述,同时提出该技术目前存在的问题和未来的展望。

本文引用格式

陈笋 . 先天性心脏病宫内介入治疗现状与展望[J]. 临床儿科杂志, 2024 , 42(10) : 833 -836 . DOI: 10.12372/jcp.2024.24e0967

Abstract

Fetal cardiac intervention (FCI) has evolved since its inception in 1991. With the improvement in technical success rates, reduction in complications, and enhancement of fetal outcomes, this technique has gradually gained recognition and promotion. The establishment of the International Fetal Cardiac Intervention Registry has facilitated international exchange and technological development in this field, with over 400 clinical cases reported worldwide. In China, several medical institutions in Guangdong, Shanghai, Qingdao, Chongqing, and other regions have initiated in-utero cardiac intervention treatments, although the number of cases remains limited. This article summarized the types of fetal in-utero cardiac interventions, the procedural process, surgical complications, indications for treatment, and treatment outcomes, while also highlighting current challenges and future prospects of the technology.

参考文献

[1] Maxwell D, Allan L, Tynan MJ. Balloon dilatation of the aortic valve in the fetus: a report of two cases[J]. Br Heart J, 1991, 65(5): 256-258.
[2] Tworetzky W, Marshall AC. Fetal interventions for cardiac defects[J]. Pediatr Clin North Am, 2004, 51(6): 1503-1513.
[3] Moon-Grady AJ, Morris SA, Belfort M, et al. International Fetal Cardiac Intervention Registry: A worldwide collaborative description and preliminary outcomes[J]. J Am Coll Cardiol, 2015, 66(4): 388-399.
[4] 庞程程, 潘微, 张智伟, 等. 室间隔完整的严重肺动脉瓣狭窄或闭锁胎儿心脏介入治疗二例[J]. 中华儿科杂志, 2018, 56(6): 445-450.
[5] Liqing Z, Lei W, Hongping X, et al. Prognosis and outcome of intrauterine treatment of fetuses with critical congenital heart disease[J]. Chin Med J (Engl), 2024, 137(12): 1431-1436.
[6] Friedman KG, Tworetzky W. Fetal cardiac interventions: Where do we stand?[J]. Arch Cardiovasc Dis, 2020, 113(2): 121-128.
[7] Jantzen DW, Moon-Grady AJ, Morris SA, et al. Hypo- plastic left heart syndrome with intact or restrictive atrial septum: a report from the International Fetal Cardiac Intervention Registry[J]. Circulation, 2017, 136(14): 1346-1349.
[8] Butera G, Cheatham JP, Pedra CAC, et al. Fetal and hybrid procedures in congenital heart diseases[M]. Switzerland: Springer, 2016: 31-60.
[9] 蔡蕾裔, 赵莉晴, 王磊, 等. 宫内心脏介入治疗胎儿危重型先天性心脏病5例报告[J]. 临床儿科杂志, 2024, 42(1): 35-39.
[10] Rebizant B, Kolesnik A, Grzyb A, et al. Fetal cardiac interventions-are they safe for the mothers?[J]. J Clin Med, 2021, 10: 851.
[11] Araujo Júnior E, Tonni G, Chung M, et al. Perinatal outcomes and intrauterine complications following fetal intervention for congenital heart disease: systematic review and meta-analysis of observational studies[J]. Ultrasound Obstet Gynecol, 2016, 48(4): 426-433.
[12] Tulzer A, Arzt W, Tulzer G. Fetal aortic valvuloplasty may rescue fetuses with critical aortic stenosis and hydrops[J]. Ultrasound Obstet Gynecol, 2021, 57: 119-125.
[13] M?kikallio K, McElhinney DB, Levine JC, et al. Fetal aortic valve stenosis and the evolution of hypoplastic left heart syndrome: patient selection for fetal intervention[J]. Circulation, 2006, 113(11): 1401-1405.
[14] Hogan WJ, Grinenco S, Armstrong A, et al. Fetal cardiac intervention for pulmonary atresia with intact ventricular septum: International Fetal Cardiac Intervention Registry[J]. Fetal Diagn Ther, 2020: 1-9.
[15] Callahan R, Friedman KG, Tworetzky W, et al. Technical success and serious adverse events for fetal aortic valvuloplasty in a large 20-year cohort[J]. JACC Adv, 2024, 3(3): 100835.
文章导航

/